Use of the guidelines directed medical therapy after coronary artery bypass graft surgery in Saudi Arabia

Background: incidence of cardiovascular diseases in Saudi Arabia is growing and more patients are expected to have cardiac revascularization surgery. Optimal pharmacotherapy management with Guideline Directed Medical Therapy (GDMT) post coronary artery bypass grafting (CABG) plays an important role...

Full description

Bibliographic Details
Main Authors: Khalid A. Alburikan, Rakan I. Nazer
Format: Article
Language:English
Published: Elsevier 2017-09-01
Series:Saudi Pharmaceutical Journal
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1319016416301414
_version_ 1819022853054398464
author Khalid A. Alburikan
Rakan I. Nazer
author_facet Khalid A. Alburikan
Rakan I. Nazer
author_sort Khalid A. Alburikan
collection DOAJ
description Background: incidence of cardiovascular diseases in Saudi Arabia is growing and more patients are expected to have cardiac revascularization surgery. Optimal pharmacotherapy management with Guideline Directed Medical Therapy (GDMT) post coronary artery bypass grafting (CABG) plays an important role in the prevention of adverse cardiovascular outcomes. The objective of this study was to assess the utilization of GDMT for secondary prevention in CABG patients and determine whether specific patients' characteristics can influence GDMT utilization. Method: A retrospective chart review of patients discharged from the hospital after CABG surgery from April 2015 to April 2016. The primary outcome was the utilization of secondary prevention GDMT after CABG surgery - aspirin, B-blockers, statin and angiotensin-converting enzyme inhibitors (ACEI) (or angiotensin receptor blockers (ARB) in ACEI-intolerant patients). The proportions of eligible and ideal patients who received treatment were calculated, and mixed-effects logistic regression was used to estimate odds ratios (OR) for the association of age, gender or patient nationality with the use of GDMT. Results: A total number of 119 patients included in the analysis. The median age of the cohort was 57.3 ± 11 years, and 83% were male (83.2%). Nearly 69.7% of patients had diabetes, and 82% had a previous diagnosis of hypertension. Nearly 91% received aspirin therapy and the rate was lower for B-blocker and statin. The rate of GDMT utilization did not change with the change in patient’s age, gender or nationality. Conclusion: Despite adjustments for contraindications to GDMT, the rate of GDMT utilization was suboptimal.
first_indexed 2024-12-21T04:29:35Z
format Article
id doaj.art-0d5b80b35c064826b76b20b84b72428b
institution Directory Open Access Journal
issn 1319-0164
language English
last_indexed 2024-12-21T04:29:35Z
publishDate 2017-09-01
publisher Elsevier
record_format Article
series Saudi Pharmaceutical Journal
spelling doaj.art-0d5b80b35c064826b76b20b84b72428b2022-12-21T19:15:58ZengElsevierSaudi Pharmaceutical Journal1319-01642017-09-0125681982210.1016/j.jsps.2016.12.007Use of the guidelines directed medical therapy after coronary artery bypass graft surgery in Saudi ArabiaKhalid A. Alburikan0Rakan I. Nazer1College of Pharmacy, King Saud University, Riyadh, Saudi ArabiaCollege of Medicine, King Saud University, Riyadh, Saudi ArabiaBackground: incidence of cardiovascular diseases in Saudi Arabia is growing and more patients are expected to have cardiac revascularization surgery. Optimal pharmacotherapy management with Guideline Directed Medical Therapy (GDMT) post coronary artery bypass grafting (CABG) plays an important role in the prevention of adverse cardiovascular outcomes. The objective of this study was to assess the utilization of GDMT for secondary prevention in CABG patients and determine whether specific patients' characteristics can influence GDMT utilization. Method: A retrospective chart review of patients discharged from the hospital after CABG surgery from April 2015 to April 2016. The primary outcome was the utilization of secondary prevention GDMT after CABG surgery - aspirin, B-blockers, statin and angiotensin-converting enzyme inhibitors (ACEI) (or angiotensin receptor blockers (ARB) in ACEI-intolerant patients). The proportions of eligible and ideal patients who received treatment were calculated, and mixed-effects logistic regression was used to estimate odds ratios (OR) for the association of age, gender or patient nationality with the use of GDMT. Results: A total number of 119 patients included in the analysis. The median age of the cohort was 57.3 ± 11 years, and 83% were male (83.2%). Nearly 69.7% of patients had diabetes, and 82% had a previous diagnosis of hypertension. Nearly 91% received aspirin therapy and the rate was lower for B-blocker and statin. The rate of GDMT utilization did not change with the change in patient’s age, gender or nationality. Conclusion: Despite adjustments for contraindications to GDMT, the rate of GDMT utilization was suboptimal.http://www.sciencedirect.com/science/article/pii/S1319016416301414Guideline Directed Medical Therapy (GDMT)Coronary artery bypass grafting (CABG)Secondary preventionPharmacotherapy
spellingShingle Khalid A. Alburikan
Rakan I. Nazer
Use of the guidelines directed medical therapy after coronary artery bypass graft surgery in Saudi Arabia
Saudi Pharmaceutical Journal
Guideline Directed Medical Therapy (GDMT)
Coronary artery bypass grafting (CABG)
Secondary prevention
Pharmacotherapy
title Use of the guidelines directed medical therapy after coronary artery bypass graft surgery in Saudi Arabia
title_full Use of the guidelines directed medical therapy after coronary artery bypass graft surgery in Saudi Arabia
title_fullStr Use of the guidelines directed medical therapy after coronary artery bypass graft surgery in Saudi Arabia
title_full_unstemmed Use of the guidelines directed medical therapy after coronary artery bypass graft surgery in Saudi Arabia
title_short Use of the guidelines directed medical therapy after coronary artery bypass graft surgery in Saudi Arabia
title_sort use of the guidelines directed medical therapy after coronary artery bypass graft surgery in saudi arabia
topic Guideline Directed Medical Therapy (GDMT)
Coronary artery bypass grafting (CABG)
Secondary prevention
Pharmacotherapy
url http://www.sciencedirect.com/science/article/pii/S1319016416301414
work_keys_str_mv AT khalidaalburikan useoftheguidelinesdirectedmedicaltherapyaftercoronaryarterybypassgraftsurgeryinsaudiarabia
AT rakaninazer useoftheguidelinesdirectedmedicaltherapyaftercoronaryarterybypassgraftsurgeryinsaudiarabia